Heavy Metals and Cardiovascular Disease: Results from the National Health and Nutrition Examination Survey (NHANES) 1999-2006AGARWAL, Shikhar; ZAMAN, Tarique; MURAT TUZCU, E et al.Angiology. 2011, Vol 62, Num 5, pp 422-429, issn 0003-3197, 8 p.Article

Cardiovascular manifestations of rheumatologic diseasesROMAN, Mary J; SALMON, Jane E.Circulation (New York, N.Y.). 2007, Vol 116, Num 20, pp 2346-2355, issn 0009-7322, 10 p.Article

Surrogate markers for cardiovascular disease : Functional markersCOHN, Jay N; QUYYUMI, Arshed A; HOLLENBERG, Norman K et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 25, pp 31-46, issn 0009-7322, 16 p., SUPArticle

Surrogate markers for cardiovascular disease : Structural markersMANCINI, G. B; DAHLÖF, Bjorn; DIEZ, Javier et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 25, pp 22-30, issn 0009-7322, 9 p., SUPArticle

Male cardiovascular mortality and dietary markers in 25 population samoles of 16 countriesYAMORI, Yukio; LONGJIAN LIU; MIZUSHIMA, Shunsaku et al.Journal of hypertension. 2006, Vol 24, Num 8, pp 1499-1505, issn 0263-6352, 7 p.Article

α-Lipoic acid and cardiovascular diseaseWOLLIN, Stephanie D; JONES, Peter J. H.The Journal of nutrition. 2003, Vol 133, Num 11, pp 3327-3330, issn 0022-3166, 4 p.Article

Sexual Activity and Cardiovascular Disease: A Scientific Statement From the American Heart AssociationLEVINE, Glenn N; STEINKE, Elaine E; TESSLER LINDAU, Stacy et al.Circulation (New York, N.Y.). 2012, Vol 125, Num 8, pp 1058-1072, issn 0009-7322, 15 p.Article

Risk factor criteriaSTAMPFER, Meir J; RIDKER, Paul M; DZAU, Victor J et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 25, pp 3-5, issn 0009-7322, 3 p., SUPArticle

Inflammatory markers and onset of cardiovascular events: Results from the health ABC studyCESARI, Matteo; PENNINX, Brenda W. J. H; PAHOR, Marco et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 19, pp 2317-2322, issn 0009-7322, 6 p.Article

Personalized Cardiovascular Medicine and Drug Development: Time for a New ParadigmLOSCALZO, Joseph.Circulation (New York, N.Y.). 2012, Vol 125, Num 4, pp 638-645, issn 0009-7322, 8 p.Article

MicroRNAs Add a New Dimension to Cardiovascular DiseaseSMALL, Eric M; FROST, Robert J. A; OLSON, Eric N et al.Circulation (New York, N.Y.). 2010, Vol 121, Num 8, pp 1022-1032, issn 0009-7322, 11 p.Article

No Shorter Telomeres in Subjects With a Family History of Cardiovascular Disease in the Asklepios StudyDE MEYER, Tim; DAELE, Caroline M. Van; RIETZSCHEL, Ernst R et al.Arteriosclerosis, thrombosis, and vascular biology. 2012, Vol 32, Num 12, pp 3076-3081, issn 1079-5642, 6 p.Article

Defining the research priorities to fight the burden of cardiovascular diseases in Latin AmericaLOPEZ-JARAMILLO, Patricio.Journal of hypertension. 2008, Vol 26, Num 9, pp 1886-1889, issn 0263-6352, 4 p.Article

Gender differences of cardiovascular disease : New perspectives for estrogen receptor signalingMEYER, Matthias R; HAAS, Elvira; BARTON, Matthias et al.Hypertension (Dallas, Tex. 1979). 2006, Vol 47, Num 6, pp 1019-1026, issn 0194-911X, 8 p.Article

Baseline ICAM-1 and VCAM-1 Are Increased in Initially Healthy Middle-Aged Men Who Develop Cardiovascular Disease During 6.6 Years of Follow-UpSCHMIDT, Caroline; HULTHE, Johannes; FAGERBERG, Bjorn et al.Angiology. 2009, Vol 60, Num 1, pp 108-114, issn 0003-3197, 7 p.Article

HRT and heart disease: problems and prospectsMAAS, Angela H. E. M; VAN DER GRAAF, Yolanda; VAN DER SCHOUW, Yvonne T et al.Maturitas (Amsterdam). 2004, Vol 47, Num 4, pp 255-258, issn 0378-5122, 4 p.Conference Paper

Autonomic Neural Regulation of the Immune System Implications for Hypertension and Cardiovascular DiseaseABBOUD, François M; HARWANI, Sailesh C; CHAPLEAU, Mark W et al.Hypertension (Dallas, Tex. 1979). 2012, Vol 59, Num 4, pp 755-762, issn 0194-911X, 8 p.Article

Low priority of cardiovascular and chronic diseases on the global health agenda : A cause for concernFUSTER, Valentin; VOUTE, Janet; HUNN, Marilyn et al.Circulation (New York, N.Y.). 2007, Vol 116, Num 17, pp 1966-1970, issn 0009-7322, 5 p.Article

Signal switching, crosstalk, and arrestin scaffolds : Novel G protein-coupled receptor signaling in cardiovascular diseaseSMITH, Nicola J; LUTTRELL, Louis M.Hypertension (Dallas, Tex. 1979). 2006, Vol 48, Num 2, pp 173-179, issn 0194-911X, 7 p.Article

Air pollution and cardiovascular diseaseFRANCHINI, Massimo; MANNUCCI, Pier Mannuccio.Thrombosis research. 2012, Vol 129, Num 3, pp 230-234, issn 0049-3848, 5 p.Conference Paper

Statin Therapy—Part II: Clinical Considerations for Cardiovascular DiseaseSADOWITZ, Benjamin; SEYMOUR, Keri; COSTANZA, Michael J et al.Vascular and endovascular surgery. 2010, Vol 44, Num 6, pp 421-433, issn 1538-5744, 13 p.Article

LDL-cholestérol et maladies cardiovasculairesBRUCKERT, E.Archives des maladies du coeur et des vaisseaux. Pratique. 2004, Num 134, pp 36-38, issn 1261-694X, 3 p.Article

Statin Therapy—Part I: The Pleiotropic Effects of Statins in Cardiovascular DiseaseSADOWITZ, Benjamin; MAIER, Kristopher G; GAHTAN, Vivian et al.Vascular and endovascular surgery. 2010, Vol 44, Num 4, pp 241-251, issn 1538-5744, 11 p.Article

Physical Activity and Cardiovascular Disease Prevention : Current RecommendationsKOKKINOS, Peter.Angiology. 2008, Vol 59, issn 0003-3197, 28S-29S, SUP2Conference Paper

The Impact of Prevention on Reducing the Burden of Cardiovascular DiseaseKAHN, Richard; ROBERTSON, Rose Marie; SMITH, Robert et al.Circulation (New York, N.Y.). 2008, Vol 118, Num 5, pp 576-585, issn 0009-7322, 10 p.Article